Fundraising Fox
Macrogenics Inc
NASDAQ: MGNXIncorporated in Delaware · 7 known investors
Find your way into Macrogenics Inc
Sign up to see every warm intro you have to Macrogenics Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Macrogenics Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Founders & leadership
Investors · 7
How we know: Havencrest Capital Management's portfolio page · Not right? Tell us
How we know: Ridgeback Capital's portfolio page · Not right? Tell us
How we know: RiverVest Venture Partners's portfolio page · Not right? Tell us
How we know: Saints Capital's portfolio page · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
3 people who came through Macrogenics Inc went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Macrogenics Inc.
Frequently asked questions
- What does Macrogenics Inc do?
- MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
- Who are Macrogenics Inc's investors?
- Macrogenics Inc's investors include Havencrest Capital Management, Ridgeback Capital, RiverVest Venture Partners, Saints Capital, Sanofi Ventures, La Caisse, TPG.